Cullinan Oncology LLC Working Capital to Net Assets Ratio
Cullinan Oncology LLC working capital to net assets ratio. Cullinan Oncology LLC (CGEM) has a Working Capital to Net Assets ratio of 89.1% as of March 2026. Working capital of $326.25 Million (current assets of $361.41 Million minus current liabilities of $35.15 Million) is measured against net assets of $366.17 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Cullinan Oncology LLC tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cullinan Oncology LLC (2013–2025)
Working capital to net assets ratio of Cullinan Oncology LLC from 2013 to 2025. This chart shows how Cullinan Oncology LLC's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 89.1%, reflecting working capital of $326.25 Million against net assets of $366.17 Million USD. See defensive interval ratio of Cullinan Oncology LLC to measure how many days the company can operate on defensive assets alone.
Cullinan Oncology LLC Working Capital to Net Assets Ratio by Year (2013–2025)
Cullinan Oncology LLC working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cullinan Oncology LLC from 2013 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CGEM current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 85.4% | $349.01 Million | $408.73 Million | $386.76 Million | $37.74 Million | ▲ +20.3 pp |
| 2024 | 65.1% | $384.02 Million | $590.33 Million | $414.67 Million | $30.65 Million | ▼ -34.5 pp |
| 2023 | 99.6% | $452.05 Million | $453.89 Million | $480.19 Million | $28.14 Million | ▲ +15.1 pp |
| 2022 | 84.5% | $451.97 Million | $535.03 Million | $474.47 Million | $22.50 Million | ▲ +17.5 pp |
| 2021 | 67.0% | $284.82 Million | $425.37 Million | $296.56 Million | $11.75 Million | ▼ -31.9 pp |
| 2020 | 98.8% | $197.96 Million | $200.31 Million | $212.28 Million | $14.32 Million | ▲ +343.3 pp |
| 2019 | -244.5% | $97.57 Million | $-39.91 Million | $100.09 Million | $2.52 Million | ▼ -85.2 pp |
| 2018 | -159.3% | $32.90 Million | $-20.65 Million | $34.22 Million | $1.32 Million | ▼ -201.8 pp |
| 2016 | 42.5% | $-244.44K | $-574.85K | $3.44K | $247.88K | ▲ +29.9 pp |
| 2015 | 12.6% | $-156.62K | $-1.24 Million | $118.00 | $156.74K | ▲ +5.6 pp |
| 2014 | 7.0% | $-79.09K | $-1.14 Million | $6.34K | $85.43K | ▲ +2.8 pp |
| 2013 | 4.2% | $-41.91K | $-1.00 Million | $12.74K | $54.66K | — |